stock-mb-logo-androidstock-mb-logo-ios
Stock Screener App
Free - Play StoreApp Store
InstallInstall
logo
Halozyme Therapeutics IncHALO
$95.800.18%-0.17

Halozyme Therapeutics Inc (HALO)

Halozyme Therapeutics Inc stock is traded at $95.80, with a volume of 1,609,368. It is down -0.18% in the last 24 hours and down -21.80% over the past month. Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. ENHANZE drug delivery technology was introduced with the proprietary enzyme rHuPH20, to facilitate the subcutaneous delivery of injected drugs and fluids, with the goal of improving the patient experience with rapid SC delivery and reduced treatment burden. The company's operations are based in the United States, with minimal long-lived assets located internationally.
Previous Close:
$95.97
Open:
$95.29
24h Volume:
1,609,368
Relative Volume:
0.61
Market Cap:
$10.92B
Revenue:
$1.51B
Net Income/Loss:
$348.84M
P/E Ratio:
34.45
EPS:
$2.78
Net Cash Flow:
$667.65M
1W Performance:
-4.84%
1M Performance:
-21.80%
6M Performance:
+39.39%
1Y Performance:
+36.37%
1-Day Range:
$95.01$97.96
1-Week Range:
$94.93$101.75
52-Week Range:
$61.23$134.00

Halozyme Therapeutics Inc Stock (HALO) Company Profile

Name
Halozyme Therapeutics Inc
Phone
(858) 794-8889
Address
12390 EL CAMINO REAL, SAN DIEGO, CA, USA
Employee
423
Next Earnings Date
-
Latest SEC Filings
SEC
HALO's Discussions on X
X

 

Market Cap

 

Revenue

 

Net Income

 

Cash Flow

 

EPS

 

Halozyme Therapeutics Inc Stock (HALO) Financials Data

Similar to HALO